(2Z)-5-amino-3-oxo-7-(thiophen-2-yl)-2-(thiophen-2-ylmethylidene)-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile | 106642-94-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (2Z)-5-amino-3-oxo-7-(thiophen-2-yl)-2-(thiophen-2-ylmethylidene)-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile
• 英文别名: (2Z)-5-amino-3-oxo-7-thiophen-2-yl-2-(thiophen-2-ylmethylidene)-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile
• CAS: 106642-94-8
• 化学式: C₁₈H₁₀N₄OS₃
• 分子量: 394.502
• InChiKey: YKVPEDPSIBRJCY-AUWJEWJLSA-N

物化性质

• 沸点：
  715.5±60.0 °C(Predicted)
• 密度：
  1.61±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  26
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  176
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  (E)-2-(4-Hydroxy-thiazol-2-yl)-3-thiophen-2-yl-acrylonitrile 在 吡啶 、 sodium methylate 作用下， 以 甲醇 为溶剂， 反应 5.0h， 生成 (2Z)-5-amino-3-oxo-7-(thiophen-2-yl)-2-(thiophen-2-ylmethylidene)-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile
  参考文献：
  名称：

  Elnagdi, Mohamed Hilmy; Elmoghayar, Mohamed Rifat Hamza; Elghandour, Ahmed Hafez Hussein, Collection of Czechoslovak Chemical Communications, 1990, vol. 55, # 3, p. 745 - 751

  摘要：

  DOI：

文献信息

• Activated nitriles in heterocyclic synthesis: Synthesis of 6-thiophen-2-yl and 6-furan-2-ylthiazolo[2,3—a]pyridine derivatives
  作者：Soad Abdel Meguid Osman、Galal Eldin Hamza Elgemeie、Galal Abdel Moein Nawar、Mohamed Hilmy Elnagdi

  DOI：10.1007/bf00809177

  日期：1986.1
• HILMY, ELNAGDI MOHAMED;ELMOGHAYAR, MOHAMED RIFAT HAMZA;ELGHANDOUR, AHMED +, COLLECT. CZECHOSL. CHEM. COMMUN., 55,(1990) N, C. 745-751
  作者：HILMY, ELNAGDI MOHAMED、ELMOGHAYAR, MOHAMED RIFAT HAMZA、ELGHANDOUR, AHMED +

  DOI：——

  日期：——
• POLYHYDROQUINOLINE COMPOUNDS AND DIHYDROPYRIDINE COMPOUNDS FOR INHIBITING BETA-AMYLOID PRODUCTION
  申请人：Mullan Michael J.

  公开号：US20100119599A1

  公开（公告）日：2010-05-13

  Provided are methods of treating or reducing the risk of developing beta-amyloid production, beta-amyloid deposition, beta-amyloid neurotoxicity (including abnormal hyperphosphorylation of tau) and microgliosis associated with cerebral accumulation of Alzheimer's amyloid by administering therapeutically effective amounts of polyhydroquinoline and dihydropyridine compounds which decrease Abeta production in cells. Further provided are methods for diagnosing diseases associated with cerebral accumulation of Alzheimer's amyloid in animals or humans by administering diagnostically effective amounts of polyhydroquinoline and dihydropyridine compounds which decrease Abeta production in cells.